In conclusion, GNF-2 significantly inhibits NF-κB activation and LPS-induced pro-inflammatory molecules including TNF-α and NO in microglia and in vivo models of chronic inflammatory and neuropathic pain. The gene discussed is NFKB1; the disease is neuropathic pain.